PERGOVERIS (300 IU + 150 IU)/0.48 ml, solution for injection in a pre-filled pen pen, 0.48 ml + 5 needles
Active ingredients: Follitropin alpha, Lutropin alfa
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionpen, 0.48 ml + 5 needlessous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PERGOVERIS (300 UI + 150 UI)/0,48 mL, solution injectable en stylo prérempli
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 stylo prérempli en verre de 0,48 mL + 5 aiguilles
- Marketing authorisation holder
- MERCK EUROPE (PAYS-BAS)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 20 Jun 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67877476CIP73008921CIP133400930089217Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FOLLITROPINE ALFAsolution | 300 UI · un stylo prérempli | SA |
| LUTROPINE ALFAsolution | 150 UI · un stylo prérempli | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.